FI970503L - ICAM-4-materiaaleja ja menetelmiä - Google Patents

ICAM-4-materiaaleja ja menetelmiä Download PDF

Info

Publication number
FI970503L
FI970503L FI970503A FI970503A FI970503L FI 970503 L FI970503 L FI 970503L FI 970503 A FI970503 A FI 970503A FI 970503 A FI970503 A FI 970503A FI 970503 L FI970503 L FI 970503L
Authority
FI
Finland
Prior art keywords
icam
materials
methods
Prior art date
Application number
FI970503A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI970503A7 (fi
FI970503A0 (fi
Inventor
Patrick D Kilgannon
W Michael Gallatin
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icos Corp filed Critical Icos Corp
Publication of FI970503A0 publication Critical patent/FI970503A0/fi
Publication of FI970503A7 publication Critical patent/FI970503A7/fi
Publication of FI970503L publication Critical patent/FI970503L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Semiconductor Memories (AREA)
  • Treatment And Processing Of Natural Fur Or Leather (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Glass Compositions (AREA)
FI970503A 1995-06-07 1996-06-06 ICAM-4-materiaaleja ja menetelmiä FI970503L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/481,130 US5702917A (en) 1992-01-27 1995-06-07 Polynucleotides encoding human ICAM-4
PCT/US1996/009146 WO1996040916A1 (fr) 1995-06-07 1996-06-06 Materiaux icam-4 et procedes

Publications (3)

Publication Number Publication Date
FI970503A0 FI970503A0 (fi) 1997-02-06
FI970503A7 FI970503A7 (fi) 1997-04-04
FI970503L true FI970503L (fi) 1997-04-04

Family

ID=23910735

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970503A FI970503L (fi) 1995-06-07 1996-06-06 ICAM-4-materiaaleja ja menetelmiä

Country Status (21)

Country Link
US (1) US5702917A (fr)
EP (2) EP0789763B1 (fr)
JP (2) JP3349514B2 (fr)
CN (2) CN1597950A (fr)
AT (1) ATE224448T1 (fr)
AU (1) AU721316B2 (fr)
BR (1) BR9606440A (fr)
CA (2) CA2288401A1 (fr)
CZ (1) CZ291974B6 (fr)
DE (1) DE69623746T2 (fr)
DK (1) DK0789763T3 (fr)
ES (1) ES2183961T3 (fr)
FI (1) FI970503L (fr)
HU (1) HUP9901123A3 (fr)
IL (2) IL146447A0 (fr)
MX (1) MX9700941A (fr)
NO (1) NO317150B1 (fr)
PL (2) PL188878B1 (fr)
RU (2) RU2155345C2 (fr)
SK (1) SK284161B6 (fr)
WO (1) WO1996040916A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5702917A (en) * 1992-01-27 1997-12-30 Icos Corporation Polynucleotides encoding human ICAM-4
GB9715164D0 (en) * 1997-07-19 1997-09-24 Medical Res Council Improvements in or relating to expression of nucleic acid sequences in cerebellar cells
IL130228A0 (en) * 1997-10-02 2000-06-01 Icos Corp ICAM-4 and diagnostics uses thereof
EP0968289A1 (fr) * 1997-10-22 2000-01-05 Icos Corporation Substances icam-6 et procedes correspondants
WO2000032140A1 (fr) * 1998-11-30 2000-06-08 Ivf Sciences Colorado, Inc. Systeme et milieux de culture sequentiels utilises dans la fecondation in vitro
ES2345200T3 (es) * 2003-03-24 2010-09-17 The Scripps Research Institute Vacunas de adn contra el crecimiento tumoral y procedimientos de utilizacion de las mismas.
RU2238025C1 (ru) * 2003-06-18 2004-10-20 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова Способ ранней диагностики нейропатии зрительного нерва при отечном экзофтальме

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2080044T3 (es) * 1987-05-04 1996-02-01 Dana Farber Cancer Inst Inc Moleculas de adhesion intercelular y sus ligandos de fijacion.
PT88641B (pt) * 1987-10-02 1993-04-30 Genentech Inc Metodo para a preparacao de uma variante de adesao
US5272263A (en) * 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US5264554A (en) * 1990-01-19 1993-11-23 The Blood Center Of Southeastern Wisconsin, Inc. Platelet cell adhesion molecule and variants thereof
GB9009548D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Chimeric antibody and method
ES2134762T3 (es) * 1990-07-20 1999-10-16 Bayer Ag Formas multimericas de proteinas receptoras de rinovirus humanos.
ATE166230T1 (de) * 1990-08-31 1998-06-15 Boehringer Ingelheim Pharma Verwendung von anti-icam antikörpern zur herstellung eines präparats für die behandlung von endotoxinschock
IL102176A (en) * 1991-06-11 2001-09-13 Blood Res Center Recombinant nucleic acid molecule capable of encoding intercellular adhesion molecule 3, functional derivatives of icam-3 and pharmaceutical compositions containing icam-3 or functional derivatives thereof
US5702917A (en) * 1992-01-27 1997-12-30 Icos Corporation Polynucleotides encoding human ICAM-4
WO1993014776A1 (fr) * 1992-01-27 1993-08-05 Icos Corporation Proteine apparentee a icam

Also Published As

Publication number Publication date
PL188878B1 (pl) 2005-05-31
FI970503A7 (fi) 1997-04-04
PL318545A1 (en) 1997-06-23
JP3349514B2 (ja) 2002-11-25
HUP9901123A3 (en) 2001-10-29
FI970503A0 (fi) 1997-02-06
AU6256096A (en) 1996-12-30
CA2196431A1 (fr) 1996-12-19
CN1164870A (zh) 1997-11-12
DE69623746T2 (de) 2003-05-08
MX9700941A (es) 1998-01-31
BR9606440A (pt) 1997-09-30
EP1308514A2 (fr) 2003-05-07
EP0789763B1 (fr) 2002-09-18
DE69623746D1 (de) 2002-10-24
IL120095A0 (en) 1997-04-15
CN1152960C (zh) 2004-06-09
EP0789763A1 (fr) 1997-08-20
SK16597A3 (en) 1998-02-04
AU721316B2 (en) 2000-06-29
US5702917A (en) 1997-12-30
SK284161B6 (sk) 2004-10-05
ATE224448T1 (de) 2002-10-15
JP2003047493A (ja) 2003-02-18
CZ29297A3 (en) 1997-10-15
RU2000111744A (ru) 2002-09-10
PL188612B1 (pl) 2005-03-31
IL146447A0 (en) 2002-07-25
JPH10505508A (ja) 1998-06-02
HUP9901123A2 (hu) 1999-07-28
DK0789763T3 (da) 2003-01-27
CA2288401A1 (fr) 1996-12-19
NO317150B1 (no) 2004-08-30
CA2196431C (fr) 2000-08-15
CZ291974B6 (cs) 2003-06-18
RU2155345C2 (ru) 2000-08-27
EP1308514A3 (fr) 2004-01-02
NO970546L (no) 1997-04-07
CN1597950A (zh) 2005-03-23
NO970546D0 (no) 1997-02-06
WO1996040916A1 (fr) 1996-12-19
ES2183961T3 (es) 2003-04-01

Similar Documents

Publication Publication Date Title
FI980112L (fi) Antiparasiittiset markfortiinit ja paraherkvamidit
FI973426L (fi) Bentsopyraania sisältävät yhdisteet ja menetelmä niiden valmistamiseksi
FI973402L (fi) Uusia proteiineja ja menetelmiä proteiinien tuottamiseksi
FI942745L (fi) Fluoreeniyhdisteitä ja valmistusmenetelmä
FI972865L (fi) Hydroksimetyyli-imidatsodiatseptiinejä ja niiden esterit
FI973378A0 (fi) Laite ja menetelmä
FI980043L (fi) Ääntä vaimentava tuote ja menetelmä sen valmistamiseksi
FI953976A7 (fi) Menetelmä elastisen turvamateriaalin valmistamiseksi ja elastinen turvamateriaali
DE69629466D1 (de) Verbundwerkstoffe
BR9606984A (pt) Vassoura e conjunto de vassoura
DE59605086D1 (de) Polymerisierbares Material
DK0732379T3 (da) Pigmentholdigt kompositmateriale
DK0727466T3 (da) Pigmentholdigt kompositmateriale
FI942958L (fi) Materiaaleja ja menetelmiä osteoporoosia estävien aineiden seulomiseksi
FI960912A7 (fi) Massan valmistus- ja varastointimenetelmä ja laite
FI950829L (fi) Kuitumateriaali ja menetelmä sen valmistamiseksi
FI970503A7 (fi) ICAM-4-materiaaleja ja menetelmiä
FI970157A7 (fi) Kuitulevyjen liimat ja menetelmä niiden valmistamiseksi
FI973434A7 (fi) Aminotetralonijohdannaisia ja menetelmä niiden valmistamiseksi
FI97983B (fi) Sihtausmenetelmä ja sihti
FI972670A0 (fi) Uuudelleenkeittokelpoisia selluloosapitoisia materiaaleja
DE69614491D1 (de) 5HT1Dalpha und 5HT2A Ligande
FI970432L (fi) Epäorgaaninen kevytmateriaali ja menetelmä sen valmistamiseksi
NO982865L (no) Magnetiske materialer
FI97745C (fi) Kannatinväline ja menetelmä sen valmistamiseksi

Legal Events

Date Code Title Description
MA Patent expired